E261K (p.Glu261Lys) variant of SGCD (Delta-sarcoglycan)
E261K (p.Glu261Lys) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Autosomal recessive limb-girdle muscular dystrophy type 2F; Dilated cardiomyopat. The available variant effect predictions contribute to a CATVariant prioritization score of 0.76 / 1. The record also includes population frequency data, published literature, and structural context.
E261K (p.Glu261Lys) variant details
- p.Glu261Lys
- rs121909297
- ClinGen CA340753
- NCI-TCGA Cosmic COSV6191
- cosmic curated COSV61911
- Likely pathogenic
- Autosomal recessive limb-girdle muscular dystrophy type 2F; Dilated cardiomyopat
- Missense
- Variant Prioritization Score for Impact Estimate 0.755
- ESM-1b 1.00
- AlphaMissense 0.71
- MetaLR 0.84
- MetaSVM 0.67
- PolyPhen-2 1.00
- SIFT 0.41
- ClinVar: Likely pathogenic (Autosomal recessive limb-girdle muscular dystrophy type 2F; Dila)
- EBI: Pathogenic (in LGMDR6)
- UniProt: Pathogenic (in LGMDR6)
- Population evidence available
- Structural context available
- Cited in: A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle… (PMID 9832045)